FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

West-Ward Pharmaceutical Fentanyl Citrate Inj Recall

Fentanyl Citrate Inj

West-Ward Pharmaceutical Corporation · Cherry Hill, NJ

Risk level
Class III
Reported by FDA
Apr 1, 2015
Recall ID
D-0420-2015
Check your lot numberHow we source this data

Summary

West-Ward Pharmaceutical recalled Fentanyl Citrate Inj starting Feb 16, 2015. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0420-2015 on Apr 1, 2015. Reason: Failed Impurities/Degradation Specifications; 12 month stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications; 12 month stability testing.

Product description

Fentanyl Citrate Inj., USP, CII, 250 mcg/5 mL (50 mcg/mL) (0.05 mg/mL) 25 x 5 mL Single Dose Vials, For Intravenous or Intramuscular Use, Preservative Free, Rx Only, Manufactured by: West-Ward Pharmaceuticals, Eatontown, NJ 07724, NDC 0641-6028-25.

Lot numbers, UPCs & expiration codes

Lot #: 113312, Exp 11/2015; 014315 Exp 01/2016

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0420-2015
Classification
Class III
Status
Terminated
Recall initiated
Feb 16, 2015
FDA report date
Apr 1, 2015
Quantity
445,475 Vials
Recall type
Voluntary: Firm initiated
Recalling firm
West-Ward Pharmaceutical Corporation

Original FDA data

Every field from FDA enforcement report D-0420-2015, exactly as published.

Show all FDA fields
City
Cherry Hill
State
NJ
Status
Terminated
Country
United States
Event ID
70548
Address
2 Esterbrook Ln
Code information
Lot #: 113312, Exp 11/2015; 014315 Exp 01/2016
Postal code
08003-4002
Report date
Apr 1, 2015
Product type
Drugs
Recall number
D-0420-2015
Classification
Class III
Recalling firm
West-Ward Pharmaceutical Corporation
Product quantity
445,475 Vials
Termination date
Jul 26, 2016
Reason for recall
Failed Impurities/Degradation Specifications; 12 month stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fentanyl Citrate Inj., USP, CII, 250 mcg/5 mL (50 mcg/mL) (0.05 mg/mL) 25 x 5 mL Single Dose Vials, For Intravenous or Intramuscular Use, Preservative Free, Rx Only, Manufactured by: West-Ward Pharmaceuticals, Eatontown, NJ 07724, NDC 0641-6028-25.
Distribution pattern
Nationwide
Recall initiation date
Feb 16, 2015
Initial firm notification
Letter
Center classification date
Mar 20, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0420-2015, published Apr 1, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls